scispace - formally typeset
K

Kazuhiko Koike

Researcher at University of Tokyo

Publications -  1203
Citations -  42534

Kazuhiko Koike is an academic researcher from University of Tokyo. The author has contributed to research in topics: Hepatocellular carcinoma & Stent. The author has an hindex of 79, co-authored 1157 publications receiving 36326 citations. Previous affiliations of Kazuhiko Koike include Jikei University School of Medicine & Japanese Foundation for Cancer Research.

Papers
More filters

Hepatocellular carcinoma.

TL;DR: In this paper, the authors used non-invasive criteria to diagnose hepatocellular carcinoma (HCC) and showed that 25% of all HCCs present potentially actionable mutations, which are yet to translate into clinical practice.
Journal ArticleDOI

Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma

TL;DR: This Article contains errors in the numbering of several papers in the reference list; reference 34 is incorrectly listed as reference 44 and references 35 to 44 are incorrectly list as 34 to 43.
Journal ArticleDOI

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.

TL;DR: It is indicated that the HCV core protein has a chief role in the development of HCC, and that these transgenic mice provide good animal models for determining the molecular events in hepatocarcinogenesis with HCV infection.
Journal ArticleDOI

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

TL;DR: This transgenic animal model appears ideal for defining the molecular events that follow the expression of the viral HBx gene and are responsible for the development of liver cancer.
Journal ArticleDOI

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

TL;DR: The ability of insulin to lower the plasma glucose level in the HCV transgenic mice was impaired, as observed in chronic hepatitis C patients, providing a direct experimental evidence for the contribution of HCV in the development of insulin resistance in human HCV infection, which finally leads to theDevelopment of type 2 diabetes.